<DOC>
	<DOCNO>NCT02365571</DOCNO>
	<brief_summary>This study involve single dos LY3154207 evaluate effect LY3154207 body . There 3 part study . Part A test single increase dos LY3154207 last approximately 7 week participant . Each participant receive two dos LY3154207 , part A complete . Part B test single dose LY3154207 last approximately 5 week participant . Part B include collect fluid spinal column measure level LY3154207 . Part C include single dose LY3154207 give alone second dose give along itraconazole look change LY3154207 level . Part C last 3 week participant . Participants may enroll 1 3 part study .</brief_summary>
	<brief_title>A Study LY3154207 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Overtly healthy male female , determine medical history physical examination Female participant childbearing potential Are reliable willing make available duration study willing follow study procedure Have give write informed consent Have body mass index ( BMI ) 18 35 kilogram per square meter ( kg/m^2 ) Part B : Have medical surgical condition lumbar puncture contraindicate Part C : Have know allergy contraindication itraconazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>